Year archive

HYPHENS PHARMA INTERNATIONAL LIMITED — 2026 filings

All 17 regulatory filings released by HYPHENS PHARMA INTERNATIONAL LIMITED (1J5) in 2026, sourced directly from the official regulator.

17 Filings

2026 Period

2026 filings (17)

Filing	Released	Lang
General Announcement::Minutes of the Annual General Meeting held on 28 April 2026 AGM Information	2026-05-22	English
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Lim See Wah Regulatory Filings	2026-05-21	English
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Lim See Wah Regulatory Filings	2026-05-20	English
Asset Acquisitions and Disposals::Completion of Proposed Acquisition of the Tranche 3 Sale Shares of 18% in Ardence Pharma Sdn Bhd M&A Activity	2026-04-29	English
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Lim See Wah Regulatory Filings	2026-04-22	English
General Announcement::Responses to Substantial and Relevant Questions from Shareholders on Annual Report 2025 Annual Report	2026-04-21	English
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Lim See Wah Regulatory Filings	2026-04-21	English
Annual Reports and Related Documents:: Environmental & Social Information	2026-04-17	English
Cash Dividend/ Distribution::Mandatory AGM Information	2026-04-10	English
Annual Reports and Related Documents:: Regulatory Filings	2026-04-10	English
Annual General Meeting::Voluntary AGM Information	2026-04-10	English
REPL::Annual General Meeting::Voluntary Declaration of Voting Results & Voting Rights Announcements	2026-04-10	English
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Mr Chan Kiat Regulatory Filings	2026-03-25	English
Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer::Change of Director's Interest - Dr Tan Kia King Regulatory Filings	2026-03-02	English
General Announcement::Result Briefing FY2025 Investor Presentation	2026-02-27	English
Financial Statements and Related Announcement::Full Yearly Results Annual Report	2026-02-24	English
General Announcement::Hyphens Pharma out-licences Cerapro MED Skin Barrier Cream for six European countries Capital/Financing Update	2026-01-05	English